Broker says this ASX All Ords stock could rise 15%

Bell Potter thinks investors should be buying this growing company's shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

GenusPlus Group Ltd (ASX: GNP) shares could be in the buy zone right now.

That's the view of analysts at Bell Potter, which rate this ASX All Ords stock very highly.

Three smiling corporate people examine a model of a new building complex.

Image source: Getty Images

What is the broker saying?

Firstly, in case you are not familiar with this ASX All Ords stock, it is a service provider to mining, utilities, and other private customers across electrical plant and equipment, power, and telecommunications infrastructure.

Bell Potter highlights that GenusPlus has upgraded its earnings guidance for FY 2026 thanks to a stronger than expected first half from the Energy & Engineering and Services segments. It said:

GNP has upgraded its FY26 EBITDA growth guidance to ~35% (up from the prior guidance range of 20-25%; vs BPe of 23%). The guidance upgrade is attributed to better-than-expected 1H FY26 unaudited financial results from the Energy & Engineering and Services segments, with Infrastructure performing as per company expectations. GNP remains confident in continued earnings growth beyond FY26 given its contracted position, integration of recent acquisitions and increased momentum in secular tailwinds.

Time to buy this ASX All Ords stock

In response to the above, Bell Potter has reaffirmed its buy rating on this ASX All Ords stock with an improved price target of $8.70 (from $7.50).

Based on its current share price of $7.57, this implies potential upside of 15% for investors over the next 12 months.

Bell Potter is positive on GenusPlus due to its exposure to increased spending on renewable energy generation, storage, and transmission infrastructure. It believes this leaves it well-placed for strong growth in both FY 2026 and FY 2027. Earnings per share growth of 33.9% and 16.9%, respectively, is forecast by the broker.

Commenting on the ASX All Ords stock, its analysts said:

GNP offers investors concentrated exposure to a long-duration tailwind in rising investment levels for renewable energy generation, storage and transmission infrastructure. GNP's current record $2.6bn+ orderbook of transmission and BESS work packages confirms this secular trend. Together, with a growing recurring revenue profile, we have good visibility on near-term earnings growth.

We highlight management's track-record of exceeding guidance over the past 2 years; the FY26 guidance upgrade this early in the financial year is highly encouraging of further positive surprises to come. Our upgraded Target Price of $8.70/sh implies a NTM PEG of 1.2x, which we view as justified given our confidence in the company's outlook.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended GenusPlus Group. The Motley Fool Australia has recommended GenusPlus Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »